CD274 and neoplasm: Nitroglycerin (also called GTN), an activator of nitric oxide signaling, blocks PD-L1 expression in hypoxic tumor cells and suppresses hypoxia-driven cytotoxic T-cell apoptosis, thereby increasing the sensitivity of tumor cells to T cell-mediated cytotoxicity (45).